Stephen Ramey (@stephenrameymd) 's Twitter Profile
Stephen Ramey

@stephenrameymd

Radiation oncologist @chooseSJC. Special interests in #prostatecancer, #headandneckcancer, and #lungcancer. #radonc #pcsm #hncsm #lcsm

ID: 897120259785846784

linkhttps://www.doximity.com/pub/stephen-ramey-md-65ff calendar_today14-08-2017 15:38:32

971 Tweet

1,1K Followers

601 Following

Ryan Hutten, MD (@drhut10) 's Twitter Profile Photo

Full manuscript at IJROBP now - late toxicity is a concern for hypofractionation in postprostatectomy setting. redjournal.org/article/S0360-…

Full manuscript at IJROBP now - late toxicity is a concern for hypofractionation in postprostatectomy setting. redjournal.org/article/S0360-…
Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo

🔥 Final analysis: CheckMate 577 Adjuvant nivolumab in resected stage II/III EC/GEJC post-CRT & surgery ✅ DFS benefit maintained 21.8 vs 10.8 mo HR 0.76 (95% CI 0.63–0.91) 🧠 DMFS improved 27.3 vs 14.6 mo HR 0.75 (95% CI 0.62–0.90) ⚠️ OS not statistically significant 51.7 vs

Mark V. Mishra (@markmishramd) 's Twitter Profile Photo

#ASCO25: In COG ACNS1123, children with NGGCT treated with proton vs. photon WVRT had significantly better long-term IQ outcomes. First prospective data showing protons preserve cognition in pediatric brain RT. Photon RT linked to IQ decline over time. 🔗 meetings.asco.org/abstracts-pres…

PDBrown (@pdbrownonc) 's Twitter Profile Photo

Congrats Dr. Surendran & Colleagues Benefit memantine seen in both the SRS cohort and the HA-WBRT cohort Mayo Clinic Radiation Oncology Nadia Laack, MD MS you will be interested in this one meetings.asco.org/abstracts-pres…

Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Navigational bronchoscopy as the new standard for biopsy of lung nodules? Non-inferiority trial NEJM compared robotic bronch to transthoracic needle biopsy with similar accuracy (79% vs 74%) but bronch with lower risk of pneumothorax (3.3% vs 28.3%). nejm.org/doi/full/10.10…

gilberto lopes (@glopesmd) 's Twitter Profile Photo

#LCSM @asco PROVE ME WRONG! Early vs Late Time-of-Day (3PM cutoff) ICI dosing in 1st-line stage IIIC-IV NSCLC: randomized trial shows near doubling of PFS (13.2 vs 6.5 mo), better OS & ORR with morning infusions. Circadian rhythm matters? Will practice change? This is the

#LCSM @asco

PROVE ME WRONG!

Early vs Late Time-of-Day (3PM cutoff) ICI dosing in 1st-line stage IIIC-IV NSCLC: randomized trial shows near doubling of PFS (13.2 vs 6.5 mo), better OS & ORR with morning infusions. Circadian rhythm matters? Will practice change? This is the
Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial ⁦JAMA Surgery⁩ jamanetwork.com/journals/jamas…

Elena Castro (@ecastromarcos) 's Twitter Profile Photo

PEACE-3 trial is out! Addition of Radium-223 to enza prolonged rPFS by 3 months in 1L mCRPC. Final OS pending annalsofoncology.org/article/S0923-….

David Sher (@davidshermd) 's Twitter Profile Photo

This study reports on incredible results with adjuvant cemiplimab in high-risk cutaneous squamous cell carcinoma. nejm.org/doi/full/10.10…

Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 #ASCO25: In pts w/ 5–20 brain mets, SRS/SRT led to fewer symptoms & less functional interference vs HA-WBRT, w/ similar OS (~8.4 mo). 🔬 Phase 3 RCT (n=196) 💡 SRS/SRT = new SoC for brain mets >4? meetings.asco.org/abstracts-pres… #RadOnc #NeuroOnc #SRS #WBRT #BrainMets

📢 #ASCO25: In pts w/ 5–20 brain mets, SRS/SRT led to fewer symptoms & less functional interference vs HA-WBRT, w/ similar OS (~8.4 mo).
🔬 Phase 3 RCT (n=196)
💡 SRS/SRT = new SoC for brain mets >4?

meetings.asco.org/abstracts-pres…

#RadOnc #NeuroOnc #SRS #WBRT #BrainMets
Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨MATTERHORN🚨 🔎948 pts Stage II-IVa G/GEJ Adenocarcinoma Ph3 RCT: Peri-op FLOT +/- Durva Durva associated with: ✅⬆️EFS2 67% vs. 59%, p<0.001 ✅⬆️pCR 19% vs. 7% BUT 🚫🔺OS2 76% vs. 70%, p=NS Full pub here in NEJM : nejm.org/doi/full/10.10… #ASCO2025

🚨MATTERHORN🚨
🔎948 pts Stage II-IVa G/GEJ Adenocarcinoma
Ph3 RCT: Peri-op FLOT +/- Durva

Durva associated with:
✅⬆️EFS2 67% vs. 59%, p&lt;0.001
✅⬆️pCR 19% vs. 7%

BUT
🚫🔺OS2 76% vs. 70%, p=NS

Full pub here in <a href="/NEJM/">NEJM</a> : nejm.org/doi/full/10.10…

#ASCO2025
PDBrown (@pdbrownonc) 's Twitter Profile Photo

Randomized Trial 8 Gy vs. SBRT 20Gy Bone Met · “Negative trial” but CR rates tended to favor SBRT · No increase pain flare w/SBRT ascopubs.org/doi/10.1200/JC…

Randomized Trial 8 Gy vs. SBRT 20Gy Bone Met
· “Negative trial” but CR rates tended to favor SBRT
· No increase pain flare w/SBRT
ascopubs.org/doi/10.1200/JC…
Youssef Zeidan MD, PhD (@zeidanmd) 's Twitter Profile Photo

🔥NSABP- B51 is out! Practice changing trial supporting RT de-escalation in cN1, ypN0 breast cancer 👉longer follow up desired 👉applicability across subtypes? 👉Impact of more modern systemic therapies ? NRG Oncology ASTRO #BreastCancer nejm.org/doi/full/10.10…

David Palma, MD, PhD (@drdavidpalma) 's Twitter Profile Photo

I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️

I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. 

We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️